“Premix vs. Custom TPN” Technical Paper Sponsored by Baxa Corporation Now Posted on Expert411.com for Media Access
The “Premix vs. Custom TPN” technical paper, sponsored by Baxa Corporation, is now available at Expert411.com for media and professional access. The paper, which provides a history of nutritional best practice and an examination of the use of premixed solutions for parenteral nutrition, is authored by Louis S. Diorio, RPh, and David L. Thomas, RPh MBA, both with Certified Consultant Pharmacists Healthcare Associates , Inc of Chatham, NJ.
Denver, CO, July 18, 2007 --(PR.com)-- The “Premix vs. Custom TPN” technical paper, sponsored by Baxa Corporation, is now available at http://expert411.com/_wsn/page13.html for media and professional access. The paper, which provides a history of nutritional best practice and an examination of the use of premixed solutions for parenteral nutrition, is authored by Louis S. Diorio, RPh, and David L. Thomas, RPh MBA, both with Certified Consultant Pharmacists Healthcare Associates, Inc. of Chatham, NJ. Baxa has contracted with the team to write a series of papers on hospital pharmacy and safe drug preparation and handling issues.
In this first paper, Diorio and Thomas examine the issues surrounding the use of premixed parenteral nutrition in the hospital environment, versus compounded, or custom total parenteral nutrition (TPN). As pointed out in the overview, America’s health-system resources are now frequently stretched to the extreme, often forcing hospital management and staff to achieve a fine balance between patient care and cost. The paper examines some of the misconceptions around standardized TPNs, the use of premix solutions and the desire for the best possible patient outcomes.
Lou Diorio, RPh, is a graduate of Long Island University’s Schwartz College of Pharmacy. An adjunct Professor of Pharmacy Practice for the college, and a preceptor of pharmacy students, he is a member of the Executive Dean’s experiential education committee. Lou has extensive experience in IV and extemporaneous compounding, and lectures and consults on these topics. He has managed an FDA-registered cGMP manufacturing operation for Coram Healthcare (SoluNet™ LLC). Most recently, Lou was asked by the NJ Board of Pharmacy to join a select committee reviewing the Board’s regulatory changes in response to changes in regulation as a direct result of USP 797. Since 1985, Lou has practiced in a number of clinical settings fulfilling many roles, including Chief Operating Officer of Hebrew Hospital Corporate services, a multi-centered sub acute and LTC hospital system in NY. He also has managed and practiced in homecare, hospital, and retail settings, plus lectured and developed educational materials for several big-pharma companies on sales and marketing topics.
Dave Thomas, RPh, MBA, is a graduate of St. Louis College of Pharmacy and has a Masters degree in Business Administration, with an emphasis in Management Information Systems, from Lewis University in Romeoville, IL. Dave's experience prior to joining CCPi included Executive Technology roles for SoluNet, LLC; Baxter Healthcare's Chemo-Therapy Division, Renal Divison, Clintec Nutritional Division and the COMPASS® Group. Since 1983, Dave has practiced in several capacities. Dave is a nationally recognized expert in Automated Compounding Technologies, having written and spoken on these and other healthcare and technology topics.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.
About Certified Consultant Pharmacists Healthcare Associates, Inc.
Certified Consultant Pharmacists Healthcare Associates, Inc. (CCPi) is a Chatham, NJ-based Healthcare consulting firm founded in 1995 to provide the highest quality consulting services to the long-term care communities of NY, NJ, and PA. CCPi now provides its expertise to several areas of pharmacy practice including regional compounding, USP 797 compliance, regulatory affairs, and quality management. CCPi’s mission is to provide value through experience, expertise, and unsurpassed customer service. For more information, go to http://www.certifiedconsultantpharmacistsinc.com.
###
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com
http://www.baxa.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801, 303.669.3558
Email: maggie@absolutelypr.com
http://www.absolutelypr.com
In this first paper, Diorio and Thomas examine the issues surrounding the use of premixed parenteral nutrition in the hospital environment, versus compounded, or custom total parenteral nutrition (TPN). As pointed out in the overview, America’s health-system resources are now frequently stretched to the extreme, often forcing hospital management and staff to achieve a fine balance between patient care and cost. The paper examines some of the misconceptions around standardized TPNs, the use of premix solutions and the desire for the best possible patient outcomes.
Lou Diorio, RPh, is a graduate of Long Island University’s Schwartz College of Pharmacy. An adjunct Professor of Pharmacy Practice for the college, and a preceptor of pharmacy students, he is a member of the Executive Dean’s experiential education committee. Lou has extensive experience in IV and extemporaneous compounding, and lectures and consults on these topics. He has managed an FDA-registered cGMP manufacturing operation for Coram Healthcare (SoluNet™ LLC). Most recently, Lou was asked by the NJ Board of Pharmacy to join a select committee reviewing the Board’s regulatory changes in response to changes in regulation as a direct result of USP 797. Since 1985, Lou has practiced in a number of clinical settings fulfilling many roles, including Chief Operating Officer of Hebrew Hospital Corporate services, a multi-centered sub acute and LTC hospital system in NY. He also has managed and practiced in homecare, hospital, and retail settings, plus lectured and developed educational materials for several big-pharma companies on sales and marketing topics.
Dave Thomas, RPh, MBA, is a graduate of St. Louis College of Pharmacy and has a Masters degree in Business Administration, with an emphasis in Management Information Systems, from Lewis University in Romeoville, IL. Dave's experience prior to joining CCPi included Executive Technology roles for SoluNet, LLC; Baxter Healthcare's Chemo-Therapy Division, Renal Divison, Clintec Nutritional Division and the COMPASS® Group. Since 1983, Dave has practiced in several capacities. Dave is a nationally recognized expert in Automated Compounding Technologies, having written and spoken on these and other healthcare and technology topics.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.
About Certified Consultant Pharmacists Healthcare Associates, Inc.
Certified Consultant Pharmacists Healthcare Associates, Inc. (CCPi) is a Chatham, NJ-based Healthcare consulting firm founded in 1995 to provide the highest quality consulting services to the long-term care communities of NY, NJ, and PA. CCPi now provides its expertise to several areas of pharmacy practice including regional compounding, USP 797 compliance, regulatory affairs, and quality management. CCPi’s mission is to provide value through experience, expertise, and unsurpassed customer service. For more information, go to http://www.certifiedconsultantpharmacistsinc.com.
###
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com
http://www.baxa.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801, 303.669.3558
Email: maggie@absolutelypr.com
http://www.absolutelypr.com
Contact
Baxa Corporation
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Contact
Categories